News

Discover all the latest news from Bioprojet: events, updates, innovations… Stay informed about the latest scientific advances and new developments in our therapeutic areas.

#BIONEWS

Nov 2025

Central disorders of hypersomnolence : first human clinical trial on BP1.15205

Bioprojet, in partnership with Harmony Biosciences in the United States, has announced the launch of the first human clinical trial of BP1.15205, an orexin type 2 receptor (OX2R) agonist, aimed at treating central disorders of hypersomnolence.

READ

November 2025 events | Bioprojet | Paris
Nov 2025

November 2025 Events

Throughout the month of November, Bioprojet will be attending several congresses in allergology and sleep medicine.

READ

Oct
2025
Oct
2025
October 2025 events

October 2025 events

Throughout June, Bioprojet will be present at several congresses on cardiology, sleep, allergology, and pediatrics.

READ

sep
2025
sep
2025
[BREAKING NEWS] An international recognition for a visionary scientist

[BREAKING NEWS] An international recognition for a visionary scientist

We are proud to share that Professor Jean-Charles Schwartz , co-founder of Bioprojet, has been awarded the 2025 Distinguished Service Award by World Sleep Society.

READ

Aug
2025
Aug
2025
Bioprojet x INSV — A partnership to raise awareness of childhood narcolepsy

Bioprojet x INSV — A partnership to raise awareness of childhood narcolepsy

We are proud to collaborate with the National Institute for Sleep and Vigilance (INSV) to promote our awareness campaign on childhood narcolepsy.

READ

Jul
2025
Jul
2025
Bioprojet at the heart of innovation

Bioprojet at the heart of innovation

A new chapter for Bioprojet research near Rennes!

READ

PAGE 1 SUR 4